
German Bionic launches wearable, AI-powered exoskeleton
German Bionic announced today that it launched the Exia AI-powered exoskeleton system, its most advanced wearable to date.

German Bionic announced today that it launched the Exia AI-powered exoskeleton system, its most advanced wearable to date.

Scientists at the Mind, Brain, and Behavior Research Center at the University of Granada (CIMCYC) have revealed how, when faced with highly appetizing and unhealthy food stimuli, many overweight people or those prone to binge eating keep their impulsive system hyperactive, while their reflective or conscious thinking system takes a back seat.

Researchers have developed a first-of-its-kind device to profile the immune function of newborns. Using a single drop of blood, the BiophysicaL Immune Profiling for Infants (BLIPI) system provides real-time insights into newborns’ immune responses, enabling the early detection of severe inflammatory conditions and allowing for timely interventions.

It took Glenn Calverley a while to figure out he was having a stroke. It just felt like a really bad headache that wouldn’t go away. But then he noticed his vision had changed dramatically and he knew something was seriously wrong.

A research team led by Professor YongKeun Park of the Department of Physics, in collaboration with Professor Su-Jin Shin’s team at Yonsei University Gangnam Severance Hospital, Professor Tae Hyun Hwang’s team at Mayo Clinic, and Tomocube’s AI research team, has developed an innovative technology capable of vividly displaying the 3D structure of cancer tissues without separate staining.

3D tissue engineering, which recently has undergone other major advances in speed and accuracy, helps biomedical researchers design and test therapies for a range of diseases.

Connected monitoring device brings real-time, remote care support for pregnant patients and individuals at cardiovascular risk.

Breakthrough endovascular device advances minimally invasive arteriovenous graft creation for patients requiring hemodialysis.

Breakthrough Injectable Gel Offers Minimally Invasive Relief for Patients with Degenerative Disc Disease Across Europe.

Auxilium Biotechnologies today announced enrollment of the first patient in a pivotal trial for its NeuroSpan Bridge implant for nerve regeneration.